'Refractory anemia' presentation slideshows

Anemia Overview

Anemia Overview. Anu Thummala, M.D. Hematology/Oncology and Internal Medicine Comprehensive Cancer Centers of Nevada. Anemia. Three main mechanisms: DECREASED PRODUCTION OF RBC (HYPOPROLIFERATION) 2. INCREASED DESTRUCTION OF RBC (HEMOLYSIS) 3. ACUTE BLOOD LOSS.

2.18k views • 153 slides

the hematopoietic and lymphoid systems

1.01k views • 100 slides

Myelodysplastic syndromes

Myelodysplastic syndromes. Achievements in understanding and treatment. Myelodysplastic syndromes. Clonal hematopoietic stem cell disorder ch a racterized by ineffective hematopoiesis and peripheral cytopenias

409 views • 14 slides

MLAB 1415- Hematology Keri Brophy-Martinez

MLAB 1415- Hematology Keri Brophy-Martinez. Chapter 23: Myelodysplastic Syndromes. MYELODYSPLASTIC SYNDROMES.

214 views • 13 slides

Additional data file 8: DNA methylation of different risk groups of MDS patients

Additional data file 8: DNA methylation of different risk groups of MDS patients. A. FZD5. **. **. **. **. n=20. n=46. n=9. n=25. n=8. RAEB2, CMML2. Healthy Granulocytes. n=24. n=8. RAEB1, CMML1. 5q-, RA, RARS, RCMD, RSCMD. n=59. n=17. B. FZD8. *. *. *. n=63. n=45.

123 views • 1 slides

Additional data file 8: DNA methylation of different risk groups of MDS patients

Additional data file 8: DNA methylation of different risk groups of MDS patients. A. FZD5. **. **. **. **. n=20. n=46. n=9. n=25. n=8. RAEB2, CMML2. Healthy Granulocytes. n=24. n=8. RAEB1, CMML1. 5q-, RA, RARS, RCMD, RSCMD. n=59. n=17. B. FZD8. *. *. *. n=63. n=45.

96 views • 1 slides